Urinary exosomal microRNAs in Kawasaki disease and their changes after treatment

Hsin-Chun Huang1,2, Ho-Chang Kuo1, Hong-Ren Yu1

  • 1Department of Pediatrics, Kaohsiung Chang Gung Memorial Hospital and Chang Gung University College of Medicine, Kaohsiung, Taiwan, ROC.

Pediatric Research
|August 11, 2026
PubMed
Abstract

Insights

Urinary exosomal microRNAs (miRNAs) differ in children with Kawasaki disease (KD) and change after treatment. These findings suggest urinary exosomal miRNAs may indicate inflammatory signaling in acute KD.

Area of Science:

  • Biochemistry
  • Molecular Biology
  • Pediatrics

Background:

  • Kawasaki disease (KD) is a childhood vasculitis with significant inflammation.
  • Research on circulating microRNAs in KD exists, but urinary exosomal microRNAs (miRNAs) and their post-treatment dynamics are not well understood.

Purpose of the Study:

  • To investigate urinary exosomal miRNA profiles in children with KD compared to febrile controls.
  • To analyze dynamic changes in urinary exosomal miRNAs following intravenous immunoglobulin (IVIG) and aspirin treatment for KD.

Main Methods:

  • Isolation of urinary exosomes from children with KD and febrile controls.
  • Analysis of miRNA expression profiles using low-density arrays.
  • Evaluation of differentially expressed miRNAs before and after IVIG/aspirin treatment.
  • Gene Ontology and KEGG pathway analyses to determine biological functions.

Main Results:

  • Distinct urinary exosomal miRNA expression patterns were identified in KD subjects versus controls.
  • Several specific miRNAs (let-7g-5p, miR-26b-5p, miR-125b-5p, miR-200b-3p) showed differential expression and altered levels post-treatment.
  • Pathway analyses suggested involvement of MAPK, PI3K-Akt, Ras, and Rap1 signaling pathways.

Conclusions:

  • Urinary exosomal miRNA profiles are distinct in children with KD.
  • These miRNAs undergo changes after IVIG and aspirin treatment.
  • Urinary exosomal miRNAs show potential as indicators of inflammatory signaling in acute KD.